CervoMed Inc [NASDAQ: CRVO] gained 40.53% or 2.61 points to close at $9.05 with a heavy trading volume of 19934218 shares.
The daily chart for CRVO points out that the company has recorded -46.70% loss over the past six months.
If we look at the average trading volume of 3.98M shares, CRVO reached to a volume of 19934218 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about CervoMed Inc [CRVO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CRVO shares is $15.17 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CRVO stock is a recommendation set at 1.29. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Chardan Capital Markets have made an estimate for CervoMed Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 13, 2025. The new note on the price target was released on December 17, 2024, representing the official price target for CervoMed Inc stock.
The Average True Range (ATR) for CervoMed Inc is set at 0.85, with the Price to Sales ratio for CRVO stock in the period of the last 12 months amounting to 7.42. The Price to Book ratio for the last quarter was 1.64, with the Price to Cash per share for the same quarter was set at 5.65.
Trading performance analysis for CRVO stock
CervoMed Inc [CRVO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 307.66. With this latest performance, CRVO shares gained by 313.24% in over the last four-week period, additionally sinking by -46.70% over the last 6 months – not to mention a drop of -46.73% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CRVO stock in for the last two-week period is set at 91.00, with the RSI for the last a single of trading hit 93.67, and the three-weeks RSI is set at 85.18 for CervoMed Inc [CRVO]. The present Moving Average for the last 50 days of trading for this stock 2.59, while it was recorded at 5.96 for the last single week of trading, and 10.84 for the last 200 days.
CervoMed Inc [CRVO]: A deeper dive into fundamental analysis
CervoMed Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 15.04 and a Current Ratio set at 15.04.
CervoMed Inc [CRVO]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CRVO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CervoMed Inc go to 3.71%.
An analysis of Institutional ownership at CervoMed Inc [CRVO]
There are presently around $18.15%, or 28.01%% of CRVO stock, in the hands of institutional investors. The top three institutional holders of CRVO stocks are: AWM INVESTMENT COMPANY, INC. with ownership of 0.31 million shares, which is approximately 3.6085%. ADAGE CAPITAL PARTNERS GP, L.L.C., holding 40033.0 shares of the stock with an approximate value of $$0.69 million in CRVO stocks shares; and ADAGE CAPITAL PARTNERS GP, L.L.C., currently with $$0.13 million in CRVO stock with ownership which is approximately 0.0881%.
